Patients Stopping Weight-Loss Jabs Put On Weight at a Quadrupled Rate Than Those on Conventional Diets

A recent study suggests that individuals who come off blockbuster weight-loss injections like semaglutide or tirzepatide may regain shed pounds at a significantly accelerated pace than those who halt conventional diet and exercise programs.

Research printed in a major medical journal points out that while overweight individuals often shed substantial amounts of their body weight while undergoing treatment, the mass is regained at an estimated rate of 0.8 kg per month after stopping.

"People purchasing such drugs need to be informed of the danger of quick rebound weight gain when the medication concludes," cautioned lead investigator Dr. Susan Jebb.

That rate of recovery suggests a return to starting weight in about 18 months.

Weighing Treatments

The research, which looked at 37 of trials involving thousands of patients, compared the results of GLP-1 agonists with conventional dieting.

Scientists emphasize that individuals who lose weight through diet and exercise typically see a less rapid creep back—around 100 grams monthly—after stopping.

The Reason for the Fast Regain

Nutrition scientists propose the way of the drugs accounts for the heightened regain.

GLP-1 drugs mimic a natural hormone called GLP-1, which controls appetite.

"Sustained high doses of GLP-1 concentrations far above than the body's typical production may cause the system to produce less of its endogenous hormone, and could lessen sensitivity to its actions," noted Dr. Adam Collins, a nutrition specialist.

"Discontinuation of this hormone supplement leads to appetite is no longer kept in check, making overeating far more likely."

A Chronic Disease?

Medical guidelines suggest the injections for people with obesity-related medical conditions, alongside prescribed lifestyle changes.

Many experts contend that, given the significant potential of weight regain, the treatment should be considered ongoing.

This perspective is reinforced by drug manufacturers, who note that the findings "underscore the long-term character of excess weight," similar to managing diseases like diabetes.

User Experiences

People who have discontinued the jabs describe a intense return of appetite.

"It was like a trigger flipping and you're instantly extremely hungry," recalled a patient.

The struggle is compounded if individuals have not developed lasting lifestyle or habit modifications during therapy.

Growing Adoption

Survey data indicate that millions of adults in the UK have used these injections in the past year, with demand continuing to grow.

• Use is more common among women than males.
• The middle-aged demographic shows the highest level of interest.
• Many obtain the drugs through private healthcare rather than public health services.

In conclusion, researchers caution that while these medications are powerful agents for weight loss, they are not a standalone fix and long-term success hinges on integrated lifestyle changes.